Relationship between prostate-specific antigen and obesity in prostate cancer screening: Analysis of a large cohort in Japan

International Journal of Urology

Volumn 18, Issue 1, 2011, Pages 72-75

  Kubota, Yasuaki ^a   Seike, Kensaku ^a   Maeda, Shinichi ^a   Shinohara, Yuka ^b   Iwata, Masamitsu ^b   Sugimoto, Norio ^c  

^a TOYOTA MEMORIAL HOSPITAL   (Japan)

^b TOYOTA MOTOR CORPORATION   (Japan)

^c Sugimoto Statistics Service   (Japan)

Author keywords

Body mass index; Obesity; Prostate cancer screening; Prostate specific antigen

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CANCER SCREENING; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; GROUPS BY AGE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; COHORT STUDIES; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 78650652841     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02667.x     Document Type: Article

References (17)

1. Freedland SJ, Sun L, Kane CJ et al. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. BJU Int. 2008; 102: 969-74.
2. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348: 1625-38.
3. Freedland SJ, Banez LL, Sun LL et al. Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer Prostatic Dis. 2009; 12: 259-63.
4. Baillargeon J, Pollock BH, Kristal AR et al. The association of body mass index and prostate-specific antigen in a population-based study. Cancer 2005; 103: 1092-5.
5. Werny DM, Thompson T, Saraiya M et al. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004. Cancer Epidemiol. Biomarkers Prev. 2007; 16: 70-6.
6. Grubb RL, Black A, Izmirlian G et al. for the PLCO Project Team. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol. Biomarkers Prev. 2009; 18: 748-51.
7. Han JH, Choi NY, Bang SH et al. Relationship between serum prostate-specific antigen levels and components of metabolic syndrome in healthy men. Urology 2008; 72: 749-55.
8. Chia SE, Weber KL, Chin CM et al. Effect of aging and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study. BJU Int. 2008; 103: 1487-91.
9. Bañez LL, Hamilton RJ, Partin AW et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298: 2275-80.
10. Rundle AG, Neugut AI. Modeling the effects of obesity and weight gain on PSA velocity. Prostate 2009; 69: 1573-8.
11. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch. Intern. Med. 1916; 17: 863-71.
12. Boer P. Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am. J. Physiol. 1984; 247: 632-6.
13. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-63.
14. Ito K, Yamamoto T, Kubota Y et al. Usefulness of age-specific reference range of prostate-specific antigen for Japanese men older than 60 years in mass screening for prostate cancer. Urology 2000; 56: 278-82.
15. Gapstur SM, Gann PH, Kopp P et al. Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol. Biomarkers Prev. 2002; 11: 1041-7.
16. Muller M, Den Tonkelaar I, Thijssen JH et al. Endogenous sex hormones in men aged 40-80 years. Eur. J. Endocrinol. 2003; 149: 583-9.
17. OECD. OECD FACT BOOK 2005. Economic, Environmental and Social Statistics. OECD, Paris, France, 2005.